Antibodies against MOG have been associated with various spectrum diseases, called MOGAD, including acquired demyelinating syndromes such as optic neuritis (ON), myelitis, optic neuromyelitis (ONM), ADEM, NMOSD, or MS. This evidence concerns the gene MOG and acute disseminated encephalomyelitis.